한글목차

개요

인간화 마우스 모델 시장은 2023-20281년에 1억 860만 달러, 예측 기간 중 CAGR은 10.22%로 성장할 것으로 예측되고 있습니다.

인간화 마우스 모델 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 맞춤형 의료의 채택 확대, 인간화 마우스 모델의 혁신적 응용, 유전자 공학 기술의 진보 등이 시장을 촉진하고 있습니다.

본 조사에서는 향후 수년간 인간화 마우스 모델 시장의 성장을 촉진하는 주요 이유의 하나로 벤더의 전략적 제휴를 들고 있습니다. 또한 MAB의 생산량 증가 및 전동물 이미징의 출현은 시장의 큰 수요로 이어지고 있습니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 인간화 마우스 모델 시장 2018-2022
• 최종사용자 부문 분석 2018-2022
• 제품 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 제약회사 및 바이오테크놀러지 회사 : 시장 규모와 예측 2023-2028
• CRO : 시장 규모와 예측 2023-2028
• 학술 조사기관 : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 유전적 인간화 마우스 모델 : 시장 규모와 예측 2023-2028
• 세포 기반 인간화 마우스 모델 : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 프랑스 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Altogen labs
• Aragen Life Sciences Pvt. Ltd.
• Biocytogen
• BioSafety Research Center Inc.
• Champions Oncology Inc.
• Charles River Laboratories International Inc.
• Creative Biolabs
• Cyagen Biosciences
• Gempharmatech Co. Ltd.
• genOway
• HBM Holdings Ltd.
• Hera Biolabs Inc.
• ingenious targeting laboratory
• JSR Corp.
• PerkinElmer Inc.

제13장 부록

영문목차

Abstract

The humanized mouse model market is forecasted to grow by USD 108.6 mn during 2023-2028, accelerating at a CAGR of 10.22% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

Technavio's humanized mouse model market is segmented as below:

By End-user

• Pharmaceutical and biotechnology companies
• CROs
• Academic and research institutions

By Product

• Genetically humanized mouse model
• Cell-based humanized mouse model

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strategic alliances of vendors as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of MABs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

• Humanized mouse model market sizing
• Humanized mouse model market forecast
• Humanized mouse model market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., genOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv, Inc., JANVIER LABS, JSR Corp., Oncodesign SA, Ozgene Pty Ltd., PerkinElmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global humanized mouse model market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• 6.4 CROs - Market size and forecast 2023-2028
• Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
• 6.5 Academic and research institutions - Market size and forecast 2023-2028
• Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Genetically humanized mouse model - Market size and forecast 2023-2028
• Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• 7.4 Cell-based humanized mouse model - Market size and forecast 2023-2028
• Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
• Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Altogen labs
• Exhibit 111: Altogen labs - Overview
• Exhibit 112: Altogen labs - Product / Service
• Exhibit 113: Altogen labs - Key offerings
• 12.4 Aragen Life Sciences Pvt. Ltd.
• Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
• Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
• Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
• Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
• 12.5 Biocytogen
• Exhibit 118: Biocytogen - Overview
• Exhibit 119: Biocytogen - Product / Service
• Exhibit 120: Biocytogen - Key offerings
• 12.6 BioSafety Research Center Inc.
• Exhibit 121: BioSafety Research Center Inc. - Overview
• Exhibit 122: BioSafety Research Center Inc. - Product / Service
• Exhibit 123: BioSafety Research Center Inc. - Key offerings
• 12.7 Champions Oncology Inc.
• Exhibit 124: Champions Oncology Inc. - Overview
• Exhibit 125: Champions Oncology Inc. - Product / Service
• Exhibit 126: Champions Oncology Inc. - Key news
• Exhibit 127: Champions Oncology Inc. - Key offerings
• 12.8 Charles River Laboratories International Inc.
• Exhibit 128: Charles River Laboratories International Inc. - Overview
• Exhibit 129: Charles River Laboratories International Inc. - Business segments
• Exhibit 130: Charles River Laboratories International Inc. - Key news
• Exhibit 131: Charles River Laboratories International Inc. - Key offerings
• Exhibit 132: Charles River Laboratories International Inc. - Segment focus
• 12.9 Creative Biolabs
• Exhibit 133: Creative Biolabs - Overview
• Exhibit 134: Creative Biolabs - Product / Service
• Exhibit 135: Creative Biolabs - Key offerings
• 12.10 Cyagen Biosciences
• Exhibit 136: Cyagen Biosciences - Overview
• Exhibit 137: Cyagen Biosciences - Product / Service
• Exhibit 138: Cyagen Biosciences - Key offerings
• 12.11 Gempharmatech Co. Ltd.
• Exhibit 139: Gempharmatech Co. Ltd. - Overview
• Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
• Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
• 12.12 genOway
• Exhibit 142: genOway - Overview
• Exhibit 143: genOway - Product / Service
• Exhibit 144: genOway - Key offerings
• 12.13 HBM Holdings Ltd.
• Exhibit 145: HBM Holdings Ltd. - Overview
• Exhibit 146: HBM Holdings Ltd. - Product / Service
• Exhibit 147: HBM Holdings Ltd. - Key offerings
• 12.14 Hera Biolabs Inc.
• Exhibit 148: Hera Biolabs Inc. - Overview
• Exhibit 149: Hera Biolabs Inc. - Product / Service
• Exhibit 150: Hera Biolabs Inc. - Key offerings
• 12.15 ingenious targeting laboratory
• Exhibit 151: ingenious targeting laboratory - Overview
• Exhibit 152: ingenious targeting laboratory - Product / Service
• Exhibit 153: ingenious targeting laboratory - Key offerings
• 12.16 JSR Corp.
• Exhibit 154: JSR Corp. - Overview
• Exhibit 155: JSR Corp. - Business segments
• Exhibit 156: JSR Corp. - Key offerings
• Exhibit 157: JSR Corp. - Segment focus
• 12.17 PerkinElmer Inc.
• Exhibit 158: PerkinElmer Inc. - Overview
• Exhibit 159: PerkinElmer Inc. - Business segments
• Exhibit 160: PerkinElmer Inc. - Key news
• Exhibit 161: PerkinElmer Inc. - Key offerings
• Exhibit 162: PerkinElmer Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 163: Inclusions checklist
• Exhibit 164: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 165: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 166: Research methodology
• Exhibit 167: Validation techniques employed for market sizing
• Exhibit 168: Information sources
• 13.5 List of abbreviations
• Exhibit 169: List of abbreviations